The impact of menopause and hormone therapy on voice and nasal resonance
PDF
Cite
Share
Request
Original Papers
VOLUME: 4 ISSUE: 1
P: 38 - 41
March 2012

The impact of menopause and hormone therapy on voice and nasal resonance

Facts Views Vis ObGyn 2012;4(1):38-41
1. Logopaedic and Audiologic Sciences & Otorhinolaryngology, Ghent University, Belgium
2. Gynaecologie, Ghent University, Belgium
No information available.
No information available
PDF
Cite
Share
Request

Abstract

In an initial study it was shown that (without hormonal influences) middle-aged (premenopausal) women show a smaller frequency and intensity range and a lower fundamental frequency of the voice compared to young women. To investigate the impact of menopause on voice and nasal resonance a cross-sectional non-randomized study design was used. Vocal characteristics and nasal resonance in premenopausal and postmenopausal women without hormone therapy (HT) were compared. Postmenopausal women without HT showed a significantly lower speaking fundamental frequency (SFF) and were able to phonate lower compared to postmenopausal women with HT. The mean difference in SFF was 14 Hz. HT can also counteract the menopausal changes in SFF. The lower SFF did not result in vocal complaints. Further research about the impact of menopause and HT on voice should concentrate on elite professional voice users.

Keywords:
BMI, hormone therapy, nasal resonance, premenopausal, postmenopausal, voice